# A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke

> **NCT07318714** · PHASE1,PHASE2 · RECRUITING · sponsor: **Astellas Pharma Inc** · enrollment: 84 (estimated)

## Conditions studied

- Chronic Ischemic Stroke

## Interventions

- **DRUG:** ASP2246
- **PROCEDURE:** Brain surgery
- **PROCEDURE:** Sham surgery
- **OTHER:** Rehabilitation therapy

## Key facts

- **NCT ID:** NCT07318714
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-03
- **Primary completion:** 2030-02-28
- **Final completion:** 2030-02-28
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07318714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07318714, "A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07318714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*